Moderna and Pfizer seek COVID-19 Vaccine Emergency Use Authorizations for young children while COVID poses virtually zero threat to this age group
WASHINGTON, DC, USA, May 10, 2022 /EINPresswire.com/ -- On April 26, Pfizer submitted an application for a COVID vaccine booster for children five through eleven years of age.
This was followed by an announcement on April 28 from Moderna that it
